QT
CMPX icon

Quantbot Technologies’s Compass Therapeutics CMPX Stock Holding History

Quantbot Technologies’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$133K Buy
60,826
+60,106
+8,348% +$177K 0.01% 1397
2026
Q1 		$3.81K Buy
+720
New +$4.16K ﹤0.01% 1588
2023
Q2 		– Sell
-17
Closed -$56 – 1623
2023
Q1 		$56 Buy
+17
New +$67 ﹤0.01% 1483

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Quantbot Technologies's CMPX Position: Q2 2026 in Review

Quantbot Technologies increased its Compass Therapeutics (CMPX) stake by 8,348% in Q2 2026, buying an estimated $177K and bringing the position to 60,826 shares worth $133K. The position accounts for 0.01% of the portfolio, ranked #1397.

Quantbot Technologies first reported a position in CMPX in Q1 2023 and has held it in 3 quarters since. 216 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • Quantbot Technologies held 60,826 shares of Compass Therapeutics worth $133K as of Q2 2026.
  • Quantbot Technologies bought 60,106 Compass Therapeutics shares in Q2 2026, an estimated $177K.
  • Compass Therapeutics made up 0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1397 holding.
  • Quantbot Technologies first reported a position in Compass Therapeutics in Q1 2023 and has held it in 3 quarters since.
  • 216 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.